Tickers — X

10 tickers
Ranks this page's recent reports by score.
DENTSPLY SIRONA Inc.
XRAY·Healthcare
B ★★★Hold
Current$10.92
Target$15.50
Return+41.9%
Aug 24, 2026

Priced as a terminal business, Dentsply Sirona offers massive asymmetric upside backed by surging free cash flow and aggressive share repurchases, though investors must navigate the white-knuckle risks of a highly leveraged balance sheet and deteriorating end-market demand.

Score
76
XP Inc.
XP·Financials
A ★★★★Buy
Current$15.84
Target$23.33
Return+47.3%
Aug 20, 2026

XP is a highly profitable, cash-generating tollbooth on Brazil's secular financial deepening, trading at deeply distressed multiples while aggressively shrinking its share count, though investors must stomach extreme volatility tied to the suffocating domestic interest rate cycle.

Score
93
Xometry, Inc.
XMTR·Industrials
B ★★★Hold
Current$96.26
Target$109.59
Return+13.8%
Aug 17, 2026

Xometry is the undisputed, asset-light tollbooth digitizing the $2 trillion custom manufacturing sector with accelerating growth and expanding margins, though investors must exercise patience as the stock's premium valuation demands flawless, uninterrupted execution to prevent multiple compression.

Score
80
Xenon Pharmaceuticals Inc.
XENE·Healthcare
B ★★★Hold
Current$62.67
Target$82.68
Return+31.9%
Aug 16, 2026

Xenon Pharmaceuticals is poised to monopolize the refractory epilepsy market with a best-in-class, de-risked Kv7 opener backed by an impenetrable $1.25 billion balance sheet, though investors must monitor the FDA submission timeline and emerging Phase 3 competition from Biohaven.

Score
84
Block, Inc.
XYZ·Financials
B ★★★Hold
Current$84.20
Target$100.50
Return+19.4%
Aug 8, 2026

Block is executing a masterful, highly profitable pivot driven by Cash App lending and aggressive share repurchases at a deeply discounted valuation, though investors must remain extremely cautious of the unresolved $526 million federal compliance investigation and subprime credit exposure.

Score
80
ExxonMobil Holdings Corporation
XOM·Energy
B ★★★Hold
Current$155.44
Target$162.00
Return+4.2%
Aug 3, 2026

ExxonMobil's flawless execution of its 'value over volume' strategy in Guyana and the Permian guarantees massive cash generation, but its premium valuation and exposure to volatile chemical margins limit near-term upside.

Score
78
Xcel Energy Inc.
XEL·Utilities
B ★★★Hold
Current$78.20
Target$91.05
Return+16.4%
Aug 2, 2026

Xcel Energy leverages an unprecedented 20 GW data center pipeline and a $70 billion clean energy capital cycle to drive elite 9% EPS growth, but catastrophic wildfire exposure and immense debt-financing needs in a high-rate environment constrain the current margin of safety.

Score
77
XPO, Inc.
XPO·Industrials
B ★★★Hold
Current$197.78
Target$224.22
Return+13.4%
Aug 2, 2026

The core bull case rests on XPO continuing its flawless margin expansion into the 70s OR via AI and network density, while the bear case fears a stretched 42x P/E multiple vulnerable to any cyclical freight slowdown.

Score
75
Xylem Inc.
XYL·Industrials
B ★★★Hold
Current$125.76
Target$140.00
Return+11.3%
Jul 31, 2026

Explosive PFAS regulation and AI data center cooling tailwinds provide long-term growth, but premium valuation demands flawless execution amidst China weakness and restructuring headwinds.

Score
84